RARA CRAFT DATABASE for FDA Medical Devices
510(k)K250071

FDA DEVICE FACTS

Alma FemiLift Pixel CO2 Laser System, Delivery Devices and Accessories

Alma Lasers, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATESeptember 24, 2025PRODUCT CODEGEX

Indications for use

The Alma FemiLift Pixel CO2 Laser System and Delivery Device Accessories are intended for use in surgical applications requiring the ablation, vaporization, excision, incision, and coagulation of soft tissue in medical specialties including: aesthetic surgery (dermatology and plastic surgery), podiatry, gynecology, neurosurgery, orthopedics (soft tissue), arthroscopy (knee).The Alma FemiLift Pixel CO2 Laser System is cleared for use for the particular indications as follows: Dermatology & Plastic Surgery The ablation, vaporization, excision, incision, and coagulation of soft tissue in dermatology and plastic surgery in the performance of:

• Laser skin resurfacing

• Laser dermabrasion

• Laser burn debridement. Laser skin resurfacing (ablation and/or vaporization) for the treatment of:

• Wrinkles, rhytids, and furrows (including fines lines and texture irregularities) Clinical literature demonstrates that skin resurfacing of wrinkles, rhytids, and furrows with CO2 laser increases the amount of sub-epidermal collagen. Laser skin resurfacing (ablation and/or vaporization) of soft tissue for the reduction, removal, and/or treatment of:

• Keratoses, including actinic and seborrheic keratosis, seborrheic vulgaris, seborrheic wart, and verruca seborrhoica;

• Vermilionectomy of the lip;

• Cutaneous horns;

• Solar/actinic elastosis;

• Cheilitis, including actinic cheilitis;

• Lentigines, including lentigo maligna or Hutchinson’s malignant freckle;

• Uneven pigmentation/ dyschromia;

• Acne scars;

• Surgical scars;

• Keloids including acne keloidalis nuchae;

• Hemangiomas (including Buccal, port wine and pyogenic granulomas/granuloma pyogenicum/granuloma telagiectaticum);

• Tattoos;

• Telangiectasia;

• Removal of small skin tumors, including periungual (Koenen) and subungual fibromas;

• Superficial pigmented lesions;

• Aden sebaceous hypertrophy or sebaceous hyperplasia;

• Rhinophyma reduction;

• Cutaneous papilloma (skin tags);

• Milia;

• Debridement of eczematous or infected skin;

• Basal and squamous cell carcinoma, including keratoacanthomas, Bowen's disease (Erythroplasia of Queyrat), and Bowenoid Papulosis (BP) lesions;

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 1, 2026